Are you Dr. Pescovitz?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 29 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
550 University Blvd
# UH4601
Indianapolis, IN 46202Phone+1 317-274-4370Fax+1 317-278-3268
Summary
- Dr. Mark Pescovitz X, MD is a general surgeon in Indianapolis, Indiana.
Education & Training
University of MinnesotaResidency, Surgery, 1986 - 1987
National Institutes of Health Clinical Center/Eunice Kennedy Shriver NICHDFellowship, Pediatric Endocrinology, 1981 - 1985- University of MinnesotaResidency, Surgery, 1979 - 1981
Northwestern University The Feinberg School of MedicineClass of 1979
Clinical Trials
- Prevention of Diabetes Progression Trial (PDPT) Start of enrollment: 2000 Jul 01
- Immunosuppressive Effects of Mycophenolate Mofetil and Valganciclovir in Kidney Transplant Recipients Start of enrollment: 2003 Jan 01
- Study of ISA247 (Voclosporin) in De Novo Renal Transplantation Start of enrollment: 2006 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 34 citationsA Randomized, Double-Blind, Pharmacokinetic Study of Oral Maribavir with Tacrolimus in Stable Renal Transplant RecipientsMark D. Pescovitz, Roy D. Bloom, John D. Pirsch, J. Johnson, S. Gelone
American Journal of Transplantation. 2009-10-01 - 39 citationsPancreas after Kidney TransplantationSundaram Hariharan, J D Pirsch, Christopher Y. Lu, Laurence Chan, Todd E. Pesavento
Journal of the American Society of Nephrology. 2002-04-01 - 414 citationsRituximab, an Anti-CD20 Monoclonal Antibody: History and Mechanism of ActionMark D. Pescovitz
American Journal of Transplantation. 2006-05-01
Press Mentions
Transplantation of the SpleenSeptember 23rd, 2020
Lessons Learned from a Randomized Study of Oral Valganciclovir Versus Parenteral Ganciclovir Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients: The VICTOR TrialFebruary 16th, 2016
